Medical Advisory Board

• CEO Allcare Practice Solutions
• Current Advisory Business Board: Northern Illinois University
• Partner Ambassador Consulting (Healthcare Division) www.ambassadorconsultingsolutions.com
• Former Chief Business Strategist: IMAC Holdings, NASDAQ
• Former Co Founder Practice Business Partners
• Former Founder Progressive Health and Rehabilitation
• Former Co Founder CJ Digital Marketing and Consulting
• Naturopathic Medicine Physician, Chiropractic Medicine, Board Certification Clinical Nutrition
• Nationally Published Author Reversing Diabetes

Growth Strategy: Specializing in Organic Growth, Revenue Strategies, Marketing Strategies & Strategic Acquisitions including Exit Strategies

• CEO Allcare Practice Solutions
• Current Advisory Business Board: Northern Illinois University
• Partner Ambassador Consulting (Healthcare Division) www.ambassadorconsultingsolutions.com
• Former Chief Business Strategist: IMAC Holdings, NASDAQ
• Former Co Founder Practice Business Partners
• Former Founder Progressive Health and Rehabilitation
• Former Co Founder CJ Digital Marketing and Consulting
• Naturopathic Medicine Physician, Chiropractic Medicine, Board Certification Clinical Nutrition
• Nationally Published Author Reversing Diabetes

Growth Strategy: Specializing in Organic Growth, Revenue Strategies, Marketing Strategies & Strategic Acquisitions including Exit Strategies

• Helped Build Over $500M+ Additional Revenue Service Centers by Training Single Clinic Operators to Run Multiple Clinics Across Locations throughout the US
• Created DME Representation Strategies and Revenue Growth
• Strategic Business Franchise Consulting for a group of 52 outpatient physical rehab centers: Revenue Increase and Exit Strategies
• Consulted on Cell Biologic Applications for Pain Management Operators improving their “Business Model” for duplication and expansion
• Consulted Medical Groups to help increase their evaluations (EBITDA) by reviewing efficiencies, coding, billings and adding additional revenue sources. Exit planning.
• Operational Consulting for 50+ healthcare groups for efficiency, workflows and implementing organizational charts for expansion including more additional sites
• Created Marketing Strategies for 134 Pain Management Groups to increase new patient volume
• Consulted/Lectured Nationally on Over 50 Company’s Medical Practice Strategies
• Helping Medical and other healthcare practices improve sales in both commercial and self pay models

Dr. Hui has extensive experience in operational and strategic development of healthcare groups of various disciplines. He has owned 4 successful Regenerative Medicine Centers and has developed practice models/groups, pain centers, rehabilitation practices. He has also developed consistent marketing avenues to keep new patients flowing through the clinic doors. He has a unique skillset as a previous founder/owner of medical groups and as healthcare acquisition expert in terms of value based decisions. He possesses a work ethic that is centered on continually improving revenues based on a strategic growth model. He executes a sound business development and operational platform, along with successful marketing strategies. He is an ongoing consulting partner as a strategist for a number of healthcare marketing corporations. He uses a consistent consultative methodology that has been successful for many practices throughout the United States.

• Increase cash flow
• Implement self-pay models successfully
• Lower bad debt expense
• Improve patient/customer satisfaction with financial services
• Reduce operating cost
• Increase productivity
• Maximize EBITDA evaluations

Finally, and most importantly, he has excellent management and a cohesive vision, both for the further development of the Founder Companies and for the growth of Companies based on aggressive revenue strategies.

Dr. George F. Moricz is a nationally recognized pioneer in Functional and Regenerative Medicine, known for helping patients reverse chronic symptoms, restore vitality, and optimize longevity through personalized, integrative care. With over two decades of medical expertise, Dr. Moricz serves as a driving force behind our advanced care protocols at Alzheimer's Treatment Centers of America. Dr. Moricz received his medical degree from the University of Massachusetts Medical School and holds an undergraduate degree in Biology from Boston College. He began his clinical career in pelvic surgery and infertility, but his relentless curiosity and passion for patient-centered outcomes led him to expand his scope into hormone optimization, medical bariatrics, anti-aging medicine, and energy-based therapies. As the founder of the Youthful Blueprint System™, Dr. Moricz has treated patients from across the U.S. and abroad through concierge-style programs designed to uncover root causes and deliver customized treatment pathways. His innovations span natural sleep systems, nano-energetic formulations, and hormonal protocols that have redefined how longevity and healthspan are pursued.

Dr. George F. Moricz is a nationally recognized pioneer in Functional and Regenerative Medicine, known for helping patients reverse chronic symptoms, restore vitality, and optimize longevity through personalized, integrative care. With over two decades of medical expertise, Dr. Moricz serves as a driving force behind our advanced care protocols at Alzheimer's Treatment Centers of America. Dr. Moricz received his medical degree from the University of Massachusetts Medical School and holds an undergraduate degree in Biology from Boston College. He began his clinical career in pelvic surgery and infertility, but his relentless curiosity and passion for patient-centered outcomes led him to expand his scope into hormone optimization, medical bariatrics, anti-aging medicine, and energy-based therapies. As the founder of the Youthful Blueprint System™, Dr. Moricz has treated patients from across the U.S. and abroad through concierge-style programs designed to uncover root causes and deliver customized treatment pathways. His innovations span natural sleep systems, nano-energetic formulations, and hormonal protocols that have redefined how longevity and healthspan are pursued.

Dr. Moricz is also a two-time international best-selling author, having penned The Body Hormone Balance Revolution and Root Cause Medicine — both of which reflect his mission to empower individuals with breakthrough insights into hormonal health, brain function, and regenerative living. Today, Dr. Moricz brings his visionary leadership to ATCA's mission: blending cutting-edge science with individualized care to support cognitive resilience, clarity, and performance. Whether he's guiding patients through precision diagnostics or designing proprietary protocols, Dr. Moricz's work continues to push the boundaries of what's possible in modern brain and body health.

James N. Goldenberg, MD, FAAN, is a Board-Certified Neurologist who practiced in Palm Beach County, Florida for over 25 years. He previously served as Chief Strategy Officer of NIRA Medical, a national neurology practice platform and as Chief Medical Officer for Headlands Research, a multinational integrated clinical trial network. Dr. Goldenberg cofounded the JEM Research Institute, a clinical trial site that has helped improve lives by advancing innovative medical therapies across therapeutic areas with a focus on memory disorders. He previously served as Medical Director for Atlantic Coast Health Network, a regional super Clinically Integrated Network (CIN) affiliated with the fifth largest public health system in the US, representing over 1,900 physicians and 200,000 lives in South Florida. In that role, he was responsible for strategy, value-based care initiatives, population health, clinical oversight, and patient safety. Dr. Goldenberg also served as President and Chairman of the Board of Medical Specialists of the Palm Beaches, a large multispecialty clinic with over 80 physicians serving Palm Beach County. His undergraduate training is in psychology from the University of Florida. He received his Medical Degree from the University of South Florida. His neurology training and fellowship in neuromuscular disease were completed at the University of Miami. Dr. Goldenberg has served JFK Hospital in Atlantis, Florida in multiple leadership roles including Chairman of the Board of Trustees and was the founding Medical Director of JFK Hospital's stroke program and helped develop their Comprehensive Stroke Center.

James N. Goldenberg, MD, FAAN, is a Board-Certified Neurologist who practiced in Palm Beach County, Florida for over 25 years. He previously served as Chief Strategy Officer of NIRA Medical, a national neurology practice platform and as Chief Medical Officer for Headlands Research, a multinational integrated clinical trial network. Dr. Goldenberg cofounded the JEM Research Institute, a clinical trial site that has helped improve lives by advancing innovative medical therapies across therapeutic areas with a focus on memory disorders. He previously served as Medical Director for Atlantic Coast Health Network, a regional super Clinically Integrated Network (CIN) affiliated with the fifth largest public health system in the US, representing over 1,900 physicians and 200,000 lives in South Florida. In that role, he was responsible for strategy, value-based care initiatives, population health, clinical oversight, and patient safety. Dr. Goldenberg also served as President and Chairman of the Board of Medical Specialists of the Palm Beaches, a large multispecialty clinic with over 80 physicians serving Palm Beach County. His undergraduate training is in psychology from the University of Florida. He received his Medical Degree from the University of South Florida. His neurology training and fellowship in neuromuscular disease were completed at the University of Miami. Dr. Goldenberg has served JFK Hospital in Atlantis, Florida in multiple leadership roles including Chairman of the Board of Trustees and was the founding Medical Director of JFK Hospital's stroke program and helped develop their Comprehensive Stroke Center.

Dr. Goldenberg is an Affiliated Assistant Professor of Neurology at the Leonard M. Miller School of Medicine at the University of Miami. He has coordinated graduate medical education neurology rotations for second-year residents at JFK Hospital's University of Miami sponsored Internal Medicine Residency program and medical student rotations for fourth-year medical students at the University of Miami's Palm Beach Regional Campus. Dr. Goldenberg is an advocate for patients and physicians at the local, regional, and national levels. He is a past president and longstanding board member of the Palm Beach County Medical Society. He is responsible for the development and oversight of the Physician Leadership Academy of South Florida, training physicians to be future healthcare leaders. He has served the Florida Medical Association on the Board of Governors and has served the American Academy of Neurology on the Board of Directors and chaired their Board Planning Committee responsible for leading strategy for an organization with 40,000 members. Through advocacy, education, and the promotion of physician leadership training, he would like to help physicians prepare for the changing healthcare landscape so they are best prepared to serve their patients and communities.

Dr. Jonas Hylton is a seasoned executive with more than 20 years of global leadership in medical affairs, clinical development, and product commercialization across biotechnology and pharmaceutical sectors. He is currently the Vice President of Medical/Scientific Affairs and founder of Executive Biotech Advisors. Dr. Hylton is enthusiastic to serve on the Medical Advisory Board for the Alzheimer's Treatment Centers of America, where he brings his deep expertise in complex diseases, cross-functional strategy, clinical research and drug development to a mission that places patients and families at the center of care.

“The Alzheimer's Treatment Centers of America is leading a new era in cognitive care by bringing together science, humanity, and urgency,” said Dr. Hylton. “I joined this mission because it's not just about treating a disease. It's about restoring dignity, preserving connection, and standing with families on the front lines of one of the most personal healthcare challenges of our time.”

Dr. Jonas Hylton is a seasoned executive with more than 20 years of global leadership in medical affairs, clinical development, and product commercialization across biotechnology and pharmaceutical sectors. He is currently the Vice President of Medical/Scientific Affairs and founder of Executive Biotech Advisors. Dr. Hylton is enthusiastic to serve on the Medical Advisory Board for the Alzheimer's Treatment Centers of America, where he brings his deep expertise in complex diseases, cross-functional strategy, clinical research and drug development to a mission that places patients and families at the center of care.

“The Alzheimer's Treatment Centers of America is leading a new era in cognitive care by bringing together science, humanity, and urgency,” said Dr. Hylton. “I joined this mission because it's not just about treating a disease. It's about restoring dignity, preserving connection, and standing with families on the front lines of one of the most personal healthcare challenges of our time.”

Dr. Hylton has played a critical role in more than 10 first-to-market product launches and 9 indication expansions, supporting global regulatory approvals across oncology, hematology, rare diseases, infectious disease, and regenerative medicine. His launch experience includes groundbreaking compounds such as Xtandi®, Daurismo®, Besponsa®, Mylotarg®, Abraxane®, Emend®, and Cancidas®. Dr. Hylton's work increasingly intersects with neurodegenerative conditions, where real-world evidence, caregiver engagement, and health system readiness are essential factors for success. He has held executive roles at companies including Pfizer, Medivation, Zymeworks, and Avellino, where he led high-performing global medical and scientific affairs groups and managed multimillion-dollar budgets.

A former FDA professional, Dr. Hylton brings regulatory fluency and patient-centered strategy to every stage of development. His contributions have been recognized with numerous awards for excellence in operational and sales performance, including the prestigious CEO's Circle and Vice President's Award.

Dr. Nizar Wehbi was appointed to serve as North Dakota's State Health Officer, effective May 1st, 2021 by Gov. Doug Burgum. Prior to his appointment, Dr. Wehbi served as Deputy Director of the Center for Health Policy and Assistant Professor at the University of Nebraska Medical Center (UNMC) in Omaha. As the Center for Health Policy's Deputy Director, Wehbi conducted research and policy analysis to inform policymaking with a focus on improving population health and the efficiency and effectiveness of the U.S. healthcare system. In that role, he led initiatives to address binge drinking and colorectal cancer and conducted analysis on the healthcare workforce shortage.

As an assistant professor in the College of Public Health at UNMC, Wehbi directed the Master's in Health Administration (MHA) program, with teaching areas of focus that include health administration, health policy, the U.S. healthcare system and human resources management. He also co-led a university-wide faculty leadership program.

In addition to his medical degree, Dr. Wehbi has a master's degree in public health and an MBA from the University of Nebraska. He also holds a graduate certificate in quality, patient safety and outcomes research from the Johns Hopkins Bloomberg School of Public Health.

Dr. Nizar Wehbi was appointed to serve as North Dakota's State Health Officer, effective May 1st, 2021 by Gov. Doug Burgum. Prior to his appointment, Dr. Wehbi served as Deputy Director of the Center for Health Policy and Assistant Professor at the University of Nebraska Medical Center (UNMC) in Omaha. As the Center for Health Policy's Deputy Director, Wehbi conducted research and policy analysis to inform policymaking with a focus on improving population health and the efficiency and effectiveness of the U.S. healthcare system. In that role, he led initiatives to address binge drinking and colorectal cancer and conducted analysis on the healthcare workforce shortage.

As an assistant professor in the College of Public Health at UNMC, Wehbi directed the Master's in Health Administration (MHA) program, with teaching areas of focus that include health administration, health policy, the U.S. healthcare system and human resources management. He also co-led a university-wide faculty leadership program.

In addition to his medical degree, Dr. Wehbi has a master's degree in public health and an MBA from the University of Nebraska. He also holds a graduate certificate in quality, patient safety and outcomes research from the Johns Hopkins Bloomberg School of Public Health.

He is a Fellow of the American College of Healthcare Executives (ACHE) and currently serves a three-year term on the Board of Governors of ACHE. Wehbi has served on the National Board of Public Health Examiners since 2013 and on the Board of Directors of Clarkson College, in Omaha, since 2019.

Dr. Jonathan Artz is participating in the allopathic protocols/pathways of ATCA.

• Stanford University School of Business (Executive Education) — LEADERSHIP Program in Corporate Innovation, 1.5-Year On-Line Program (Certification, June 2023)
• Fellowship in Neurophysiology / EMG / Neuromuscular Disorders — UPMC (Presbyterian Hospital), University of Pittsburgh School of Medicine, 07/1998 – 06/1999
• Fellowship in Neurophysiology / EEG / Epilepsy — The University of Virginia (Charlottesville), 07/1997 – 06/1998
• Neurology Residency — UNC-Chapel Hill, 07/1994 – 06/1997
• Internship, Internal Medicine — UNC-Chapel Hill, 07/1993 – 06/1994
• Medical School — Emory University School of Medicine, 07/1989 – 05/1993
• Undergraduate College — Union, NY, 07/1985 – 06/1989, B.S. Biological Sciences; Phi Beta Kappa, Sigma Xi, Magna Cum Laude, Highest Honors in Biology

Dr. Jonathan Artz is participating in the allopathic protocols/pathways of ATCA.

• Stanford University School of Business (Executive Education) — LEADERSHIP Program in Corporate Innovation, 1.5-Year On-Line Program (Certification, June 2023)
• Fellowship in Neurophysiology / EMG / Neuromuscular Disorders — UPMC (Presbyterian Hospital), University of Pittsburgh School of Medicine, 07/1998 – 06/1999
• Fellowship in Neurophysiology / EEG / Epilepsy — The University of Virginia (Charlottesville), 07/1997 – 06/1998
• Neurology Residency — UNC-Chapel Hill, 07/1994 – 06/1997
• Internship, Internal Medicine — UNC-Chapel Hill, 07/1993 – 06/1994
• Medical School — Emory University School of Medicine, 07/1989 – 05/1993
• Undergraduate College — Union, NY, 07/1985 – 06/1989, B.S. Biological Sciences; Phi Beta Kappa, Sigma Xi, Magna Cum Laude, Highest Honors in Biology

• Associate Professor of Clinical Neurology — UNR MED (promoted from Assistant level, August 1, 2023)
• Chair of Committee for Clerkships and Electives — UNR MED, July 23, 2023 to present
• Director, Block 10 (Brain and Human Behavior) — since the 2023–2024 academic year, ongoing
• Co-Director, Block 10 (Neurology and Human Behavior) — UNR MED, Academic Year 2022–2023
• Director, Neurology Clerkship — University of Nevada Reno School of Medicine, July 2021 to present
• Renown Health / UNR MED Neuroscience Conference — Co-Chair for the Organizing Committee, August 17 & 18 at the Mack Auditorium (Renown Health)
• Renown Health / UNR MED Neuroscience Conference — Chairman for the Organizing Committee, September 20, 2023 at Great Basin Conference Room in Reno, NV
• Renown Health (Neuroscience Institute) — starting March 2021: Cognitive / Dementia Care and General Neurology
• Renown Health (Co-Lead) — Neurocognitive Rehabilitation and Brain Health Program, November 2022 and ongoing, working with Renown Neuropsychologist Davor Zink, PhD
• Staff Neurologist — The Permanente Medical Group (Outpatient and Hospital) at Kaiser San Rafael, August 2001 to November 2020
• Medical Director — Stroke Program (July 2016 to present) and Cognitive Disorders Program (01/2015 to 12/2020)

Neurology Representative for the following committees at Kaiser San Rafael: Technology (2013–2016); Physician Health and Wellness (2014 – 12/2020); Quality (2016 – 12/2017); Continuing Medical Education (2015 – 12/2020).

Medical Director of Stroke Services for Kaiser San Rafael Medical Center 06/2016 – 12/2020. Director of Cognitive (Dementia) Program 06/2015 – 12/2020. Director of EEG Lab, Kaiser San Rafael Medical Center 08/2001 – 12/2020. Physician Lead for Planning Committee: Kaiser Stroke Symposium — Embassy Suites, 09/2016. Preceptor for College of Marin and Dominican Nursing Students and College of Marin (Pre-Medical Students) 2015 to 2018. KP San Rafael Physician Mentorship Program — Mentor to Dr. Sirisha Nandipati.

Neurology Steering Committee 2017 to 12/2020. Telestroke Neurologist — Stroke Express Program 01/2016 – May/2020. Physician Lead for the KP Inter-Regional Stroke Conference in Monterey, CA, 04/2018. TPMG Physician Recruitment Ambassador 02/2016 to 12/2020. Physician Co-Chair for the 2019 and 2020 Kaiser National Stroke Conference (04/2019 in Anaheim and Sacramento 09/2020). Director and Committee Chair for TPMG Neurological Education, August 2018 – 12/2020. KP NCAL Virtual Reality (Mixed and Augmented) Clinical Advisory Core Team 02/2019 – 12/2020. Clinical Instructor of Neurology, University of Pittsburgh School of Medicine at UPMC (University Service Organization) 07/1999 – 07/2001.

• American Board of Electrodiagnostic Medicine (04/08/2000) — did not recertify
• American Board of Psychiatry and Neurology, with recertification in 11/2024
• American Board of Psychiatry and Neurology (added qualifications in Clinical Neurophysiology) — recertification in January 2022
• American Board of Psychiatry and Neurology, with added qualifications in Neuromuscular Medicine, 11/2024

Board of Directors, Schurig Center for Brain Injury Recovery, Larkspur, CA — 08/2016 to 04/2018, then to Advisory Board status. Director of Strategy and Special Projects, The Sustainable Sports Foundation (501c) — http://marinmarathon.com. Projects related to Kaiser San Rafael Stroke Program, 2017 and 2018 — educating Middle School and High School students about stroke awareness working with Marin County Office of Education.

UNR MED — Elective “Business in Medicine” for 4th year students and new curriculum under development working with Philip Clark, MBA, FACMPE, CHA (Senior Associate Dean of Finance at UNR MED) and Hamza Asumah, MD/MBA. UNR MED — Curriculum Renovation Committee (1st through 4th Years), 2022–2023. UNR MED — Block 5 and 10: 4 separate talks (3 for Block 10 and a 3-hour talk for Block 5) in academic year 2022–2023 on Cognition / Memory / Dementia. Renown Health — 2 to 3 lectures per month since July 2021 for the Medical School Clerkship. Grand Rounds — Renown Institute of Neurosciences, 01/2022, on Mild Cognitive Impairment and Alzheimer's Disease. Kaiser National Stroke Conference Guest Speaker — 10/2022, Virtual Reality and Neurorehabilitation. Kaiser National Stroke Conference Guest Speaker — 10/2021, Vascular Cognitive Impairment. Kaiser San Rafael Stroke Conference — 09/2016, Secondary Prevention of Stroke. Grand Rounds, Kaiser San Rafael (2017) — Driving and Reporting to the DMV. Grand Rounds, Kaiser Oakland (June 2018) — Psychiatry Department, Management of Cognitive Impairment in an Outpatient Setting. KP Inter-Regional Stroke Conference (Monterey), May 2018 — Neuro Bowl (Case Studies in Stroke). The Aging Brain Lecture — 1.5-hour discussion on 6 Saturdays per year from 2016 through 2017 at Kaiser San Rafael, open to the community. Numerous stroke- and dementia-related talks at the Medical Center's AFM, Hospitalist, and Emergency Department monthly meetings over the last 2 years (about 10 total). Keeping Your Brain Healthy — community event sponsored by the KP SRF Stroke Program at the Marin Office of Education (2018 and 2019); lifestyle factors to reduce stroke risk.

Life Style Intervention for Early Onset Alzheimer's Disease (Co-Principal Investigator) — on behalf of Renown Health System, 2021; publication June 2024 (Journal of Alzheimer's Disease and Therapeutics). Proseek Study, Co-Principal Investigator — Parkinson's Disease Pharmaceutical Study, 2022; recruitment finished in early 2024. New Ideas Study — Amyloid PET Imaging in Mild Cognitive Impairment (Principal Investigator), on behalf of Renown Health System, 2021 and ended. CREST 2 Study (Medical Management vs. Surgery for Asymptomatic Carotid Stenosis) — ongoing national study; Co-PI (while at Kaiser Permanente, 2018 to 2020).

Chief Medical Officer, Elvo Health — June 2023 to ongoing. Aquifer Neurology Assessment Team for Virtual Cases — November 2023 to December 2024. Faculty, House of Equus — UNR School of Medicine for academic year 2022–2023. Clinical Advisory Board, Neurogeneces — starting in 2022 and ongoing.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. David Wexler, a renowned Psychiatrist, has joined the Medical Advisory Board.

With more than three decades of professional experience, Dr. Wexler has held a variety of roles in the mental health field. His expertise is in biological psychiatry and psychopharmacology.

Dr. Wexler has worked as a private practitioner, staff psychiatrist (inpatient and outpatient) in a number of healthcare systems nationally and internationally, Director of Consultation/Liaison Services, team psychiatrist for an NFL franchise, physician wellness psychiatrist for a large managed care consortium, and as director of a university teaching hospital's psychopharmacology clinic. He prides himself on remaining state-of-the-science, has held academic positions at several medical schools, and has served as a web-based psychiatric consultant for primary care physicians and other medical specialists.

Dr. Wexler emphasizes collaboration with a patient's treatment team, including his or her therapist, primary care physician, and other involved specialists. This, he believes, is paramount to optimizing the quality of healthcare and, in turn, the treatment outcome.

“I'm committed to delivering a highly therapeutic clinical experience through in-person visits as well as telemedicine.” — Dr. David B. Wexler.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. David Wexler, a renowned Psychiatrist, has joined the Medical Advisory Board.

With more than three decades of professional experience, Dr. Wexler has held a variety of roles in the mental health field. His expertise is in biological psychiatry and psychopharmacology.

Dr. Wexler has worked as a private practitioner, staff psychiatrist (inpatient and outpatient) in a number of healthcare systems nationally and internationally, Director of Consultation/Liaison Services, team psychiatrist for an NFL franchise, physician wellness psychiatrist for a large managed care consortium, and as director of a university teaching hospital's psychopharmacology clinic. He prides himself on remaining state-of-the-science, has held academic positions at several medical schools, and has served as a web-based psychiatric consultant for primary care physicians and other medical specialists.

Dr. Wexler emphasizes collaboration with a patient's treatment team, including his or her therapist, primary care physician, and other involved specialists. This, he believes, is paramount to optimizing the quality of healthcare and, in turn, the treatment outcome.

“I'm committed to delivering a highly therapeutic clinical experience through in-person visits as well as telemedicine.” — Dr. David B. Wexler.

Beyond his professional endeavors, Dr. Wexler enjoys playing the oboe and piano, keeping fit, learning foreign languages, and traveling. He is currently studying Mandarin, which he was fortunate to practice while living in China.

• University of California, Los Angeles — Psychiatric Residency Completion, Psychiatry Residency Program, 1990–1994; Harbor-UCLA Psychiatric Residency Program
• University of California, San Diego — Doctor of Medicine (MD), Medicine, 1984–1990
• Harvard University — Bachelor of Arts (BA), Biology / Foreign Languages, 1980–1984

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. William Stiles III, a Urological Surgeon, Osteopathic Physician and Doctor of Natural Medicine, has joined the Medical Advisory Board.

“With over two decades of experience as an Osteopathic Physician and a distinguished career in Urologic Surgery, I am dedicated to pioneering the future of medicine through precision wellness,” said Stiles. “My approach integrates advanced data analytics to meticulously assess metabolic functions, enabling tailored strategies that address nutrition, gut health, and hormone optimization.”

Dr. Stiles specializes in crafting personalized health plans that address the unique needs of each individual. By combining deep medical knowledge with a holistic understanding of wellness, they help patients achieve significant, lasting improvements in their health and quality of life.

Respected by peers and praised by patients, Dr. Stiles is committed to pushing the boundaries of what's possible in personal health optimization. Their practice offers a rare blend of scientific rigor and compassionate care, making even the most ambitious health goals attainable.

For those seeking a truly transformative health experience guided by seasoned expertise, Dr. Stiles provides the knowledge, tools, and support to turn aspirations into reality.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. William Stiles III, a Urological Surgeon, Osteopathic Physician and Doctor of Natural Medicine, has joined the Medical Advisory Board.

“With over two decades of experience as an Osteopathic Physician and a distinguished career in Urologic Surgery, I am dedicated to pioneering the future of medicine through precision wellness,” said Stiles. “My approach integrates advanced data analytics to meticulously assess metabolic functions, enabling tailored strategies that address nutrition, gut health, and hormone optimization.”

Dr. Stiles specializes in crafting personalized health plans that address the unique needs of each individual. By combining deep medical knowledge with a holistic understanding of wellness, they help patients achieve significant, lasting improvements in their health and quality of life.

Respected by peers and praised by patients, Dr. Stiles is committed to pushing the boundaries of what's possible in personal health optimization. Their practice offers a rare blend of scientific rigor and compassionate care, making even the most ambitious health goals attainable.

For those seeking a truly transformative health experience guided by seasoned expertise, Dr. Stiles provides the knowledge, tools, and support to turn aspirations into reality.

“My entrepreneurial spirit drives my mission to redefine healthcare, making lasting health achievements accessible and tailored to individual needs,” said Dr. Stiles.

Over the course of my 20-year clinical career, during which I've performed 15,000 surgeries and treated more than 30,000 patients, I've come to recognize a profound need for a more holistic approach to health and wellness. Each individual's health journey is unique, shaped by personal experiences and circumstances. I've observed that while treating symptoms with medication can provide relief, it often fails to address the root cause of health issues. This oversight is, unfortunately, common in modern medicine.

My own health challenges, coupled with those of my patients, revealed the limitations of a purely pharmaceutical approach. This realization propelled me on an extensive quest to expand my medical toolkit, exploring diverse healing modalities to offer more comprehensive care to those seeking true healing. I firmly believe that optimal health stems from honoring the body's natural design and function. By combining this principle with cutting-edge solutions and restoring internal balance, we can achieve remarkable improvements in overall well-being.

To this end, I've integrated the best of conventional medicine, osteopathic principles, and natural healing approaches. My extensive training and experience across multiple disciplines allow me to offer a uniquely comprehensive approach to health optimization. Exceptional care, in my view, requires attentive listening, thorough investigation of underlying causes, and the application of tailored solutions that align with your individual needs and goals. My approach emphasizes lifestyle modifications and natural interventions to rebuild, repair, and achieve optimal wellness.

I am committed to providing you with the most effective tools and strategies to support your health journey, drawing from both traditional medical wisdom and innovative healing practices. I look forward to partnering with you on your path to optimal health and vitality.

• Michigan State University College of Osteopathic Medicine — 2000–2006, Urological Surgery
• Kansas State University — D.O. Medicine, 1996–2000

Dr. William Hayes, a Flight Surgeon in the U.S. Air Force, joins the Medical Advisory Board for Alzheimer's Treatment Centers of America.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. William Hayes II, a Family Medicine / Hyperbaric Medicine Physician, has joined the Medical Advisory Board. Hayes is a dual board-certified physician with an extensive background in Aerospace Medicine, as well as leadership roles and clinical practice of wound care utilized in the setting of Hyperbaric Medicine.

“My wife and I are both passionate about the effects of Alzheimer's Disease as my father lived in our home with us for the last 15 years of his life,” shared Hayes. “We intimately understand the patient-side of this grueling disease as it progressively strips away the brilliant man that was my greatest friend and advocate throughout my life. I have also seen (in my patients) how hyperbaric medicine can cause a great awakening in the Alzheimer's patient. I can only imagine what can be done under the care of ATCA.”

“I am truly honored and excited to fully accept your offer to join the Medical Advisory Board position. This opportunity is the ‘unicorn’ opportunity that I have been waiting for,” continued Dr. Hayes.

Dr. William Hayes, a Flight Surgeon in the U.S. Air Force, joins the Medical Advisory Board for Alzheimer's Treatment Centers of America.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. William Hayes II, a Family Medicine / Hyperbaric Medicine Physician, has joined the Medical Advisory Board. Hayes is a dual board-certified physician with an extensive background in Aerospace Medicine, as well as leadership roles and clinical practice of wound care utilized in the setting of Hyperbaric Medicine.

“My wife and I are both passionate about the effects of Alzheimer's Disease as my father lived in our home with us for the last 15 years of his life,” shared Hayes. “We intimately understand the patient-side of this grueling disease as it progressively strips away the brilliant man that was my greatest friend and advocate throughout my life. I have also seen (in my patients) how hyperbaric medicine can cause a great awakening in the Alzheimer's patient. I can only imagine what can be done under the care of ATCA.”

“I am truly honored and excited to fully accept your offer to join the Medical Advisory Board position. This opportunity is the ‘unicorn’ opportunity that I have been waiting for,” continued Dr. Hayes.

• Bachelor of Science in Biological Sciences — University of Nebraska
• Master of Public Health in Occupational and Environmental Health — Yale University
• Doctor of Osteopathic Medicine — Des Moines University, Osteopathic Medical Center
• Family Medicine Residency — Michigan State University
• Undersea & Hyperbaric Medicine Fellowship — USAF School of Aerospace Medicine
• Licensed in Texas, Oklahoma and Michigan

Renowned Physician Pankaj Gupta, MD, MBA is championing health equity with an innovative approach.

Dr. Gupta, a distinguished figure in the healthcare industry, is making waves with his multifaceted roles as a visionary leader and innovator. With a wealth of experience spanning over two decades, Dr. Gupta has established himself as a trailblazer in managed care, focusing on patient-centric solutions and advancing health equity.

As the Founder and CEO of EMDEE, member of the Medical Advisory Board at Alzheimer's Treatment Centers of America, and National Medicare Advantage Medical Director of Clinical Innovation at Optum, Dr. Gupta spearheads initiatives aimed at improving healthcare delivery and outcomes.

His dedication to putting patients first led him to found EQUITAAS, a nonprofit organization committed to advancing health equity. Health equity, a cornerstone of Dr. Gupta's mission, ensures that everyone has equal access to quality care, irrespective of socio-economic factors.

Renowned Physician Pankaj Gupta, MD, MBA is championing health equity with an innovative approach.

Dr. Gupta, a distinguished figure in the healthcare industry, is making waves with his multifaceted roles as a visionary leader and innovator. With a wealth of experience spanning over two decades, Dr. Gupta has established himself as a trailblazer in managed care, focusing on patient-centric solutions and advancing health equity.

As the Founder and CEO of EMDEE, member of the Medical Advisory Board at Alzheimer's Treatment Centers of America, and National Medicare Advantage Medical Director of Clinical Innovation at Optum, Dr. Gupta spearheads initiatives aimed at improving healthcare delivery and outcomes.

His dedication to putting patients first led him to found EQUITAAS, a nonprofit organization committed to advancing health equity. Health equity, a cornerstone of Dr. Gupta's mission, ensures that everyone has equal access to quality care, irrespective of socio-economic factors.

Dr. Gupta began his academic journey with a Bachelor of Arts Degree in Economics from Colgate University in 1988. He was an international banker with Citibank, then completed a Post-Baccalaureate Pre-Medical Program at Columbia University in 1992, followed by earning his Medical Degree from Saint George's University School of Medicine in 1996. Dr. Gupta further specialized with a fellowship in geriatrics at Harvard Medical School, Beth Israel Deaconess Medical Center in 1997. He advanced his expertise in general management by obtaining an Executive MBA from Cornell University's Johnson School of Business in 2004.

Driven by a passion for leveraging technology to bridge healthcare disparities, Dr. Gupta intends to create a suite of mobile apps under EQUITAAS that harness Artificial Intelligence (AI) to address gaps in health equity. Each app will align with EQUITAAS' overarching goal of enhancing access to care and promoting equitable health outcomes for all individuals.

Additionally, through his work with EMDEE, Dr. Gupta employs Machine Learning (ML) and AI to help patients assess their risk of developing behavioral conditions and dementia.

Beyond his professional accomplishments, Dr. Gupta attributes his success to the support of mentors, friends, and family. His passion for nature photography, scuba diving in the Caribbean, and DJ-ing underscores his well-rounded approach to life.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. Mark Rosenbloom (Tiger 21, LifeForce Medical Institute) has joined the Advisory Board of Alzheimer's Treatment Centers of America.

“Dr. Mark Rosenbloom brings decades of experience in root cause analysis as it relates to longevity which also has positive implications for our Alzheimer's disease and dementia patients,” said Greg Buckley, CEO of Alzheimer's Treatment Centers of America. “Mark can suggest even more incredible tools to add value to ATCA's treatment protocols.”

“I am all about anti-aging and performance when it comes to medicine,” adds Dr. Mark Rosenbloom. “When I founded LifeForce, I knew I was involved with precision medicine that has now become my purpose and my passion. When my parents suffered from Alzheimer's in their later years, I was determined to help prevent this disease, evaluate new drugs, and find effective treatments for Alzheimer's disease and dementia.”

Mark Rosenbloom, MD is the Founder and Chief Medical Officer at LIFEFORCE Medical Institute. He began his training at McGill University in Montreal, Canada, completed his MBA at Stanford University, and then fulfilled his dream to become a physician at Northwestern University Feinberg School of Medicine where he ranked #1 in clinical sciences.

Alzheimer's Treatment Centers of America (ATCA) announces that Dr. Mark Rosenbloom (Tiger 21, LifeForce Medical Institute) has joined the Advisory Board of Alzheimer's Treatment Centers of America.

“Dr. Mark Rosenbloom brings decades of experience in root cause analysis as it relates to longevity which also has positive implications for our Alzheimer's disease and dementia patients,” said Greg Buckley, CEO of Alzheimer's Treatment Centers of America. “Mark can suggest even more incredible tools to add value to ATCA's treatment protocols.”

“I am all about anti-aging and performance when it comes to medicine,” adds Dr. Mark Rosenbloom. “When I founded LifeForce, I knew I was involved with precision medicine that has now become my purpose and my passion. When my parents suffered from Alzheimer's in their later years, I was determined to help prevent this disease, evaluate new drugs, and find effective treatments for Alzheimer's disease and dementia.”

Mark Rosenbloom, MD is the Founder and Chief Medical Officer at LIFEFORCE Medical Institute. He began his training at McGill University in Montreal, Canada, completed his MBA at Stanford University, and then fulfilled his dream to become a physician at Northwestern University Feinberg School of Medicine where he ranked #1 in clinical sciences.

Dr. Rosenbloom founded PEPID LLC, which is now recognized as the premier point of care medical/drug and decision support software. Dr. Rosenbloom founded the Unicorn Children's Foundation shortly after his three-year-old son was diagnosed with autism as well as The Boca School of Autism. He is also a member of Tiger21 where his success can become more meaningful and impactful with other global entrepreneurs, investors and executives.

Alzheimer's Treatment Centers of America is pleased to announce that Keith Hanna has joined our Medical Advisory Board. Dr. Hanna brings tremendous value to our project to roll out ATCA clinics throughout the USA and the world to treat Alzheimer's disease and dementia.

Dr. Keith Hanna is the founder and CEO of IPRD Solutions, an advanced research and software development and deployment group focused on delivering healthcare solutions to the disadvantaged, primarily in Africa. Dr. Hanna embarked on this mission after meeting Bill Gates, founder of the Bill & Melinda Gates Foundation, to discuss advanced technologies and their application in lower-to-middle income countries.

Dr. Hanna's significant experience in bio-medical research, AI, and startup environments has resulted in him advising leading venture groups on emerging technologies related to Alzheimer's screening and monitoring.

Alzheimer's Treatment Centers of America is pleased to announce that Keith Hanna has joined our Medical Advisory Board. Dr. Hanna brings tremendous value to our project to roll out ATCA clinics throughout the USA and the world to treat Alzheimer's disease and dementia.

Dr. Keith Hanna is the founder and CEO of IPRD Solutions, an advanced research and software development and deployment group focused on delivering healthcare solutions to the disadvantaged, primarily in Africa. Dr. Hanna embarked on this mission after meeting Bill Gates, founder of the Bill & Melinda Gates Foundation, to discuss advanced technologies and their application in lower-to-middle income countries.

Dr. Hanna's significant experience in bio-medical research, AI, and startup environments has resulted in him advising leading venture groups on emerging technologies related to Alzheimer's screening and monitoring.

Previously, Dr. Hanna held several positions at SRI Princeton over 15 years, including Head, Vision Systems, working in the research, commercial and government domains developing and deploying pioneering algorithms, software, and systems for transformative real-world applications such as autonomous vehicle navigation, virtual reality systems, medical image processing, video surveillance, and biometrics. Dr. Hanna then co-founded eyeLock, now a major biometric company, where he held the position of CTO for over 10 years, developing and deploying pioneering biometric hardware and software solutions for commercial and consumer applications.

Dr. Hanna was awarded a multi-disciplinary Engineering Sciences degree and the DPhil degree in Medical Imaging and Computer Vision from Oxford University, including 2 years working with clinicians at the Nuffield Laboratory of Ophthalmology.

Dr. Hanna has over 25 publications and holds over 100 patents. He was awarded 7 SRI Technical Achievement Awards for his pioneering work in AI, biometrics, motion analysis and computer vision systems.

In 2007, Dr. Hanna was awarded the Most Influential Paper over the Decade Award from the International Association of Pattern Recognition.

Catherine Boyd is a healthcare executive and Physician Assistant with more than two decades of experience across acute, critical, post-acute, palliative, and hospice care, combined with senior leadership expertise in clinical quality, operational performance, and care model integration.

Her clinical background includes practice in acute care, pulmonary and intensive care medicine, emergency response leadership, post-acute care, palliative care, and hospice. She practiced in high acuity academic healthcare systems throughout Boston and New England, developing deep insight into early intervention, interdisciplinary coordination, and safe, effective transitions across settings of care.

In executive leadership roles, Catherine has led organizational performance, clinical governance, workforce strategy, and financial sustainability initiatives. Her work centers on building integrated, metrics-driven care models that improve outcomes, reduce fragmentation, and strengthen accountability across the healthcare continuum. She brings particular expertise in transitional care medicine, aligning acute, post-acute, and community-based services to support complex, high-need populations over time.

Catherine Boyd is a healthcare executive and Physician Assistant with more than two decades of experience across acute, critical, post-acute, palliative, and hospice care, combined with senior leadership expertise in clinical quality, operational performance, and care model integration.

Her clinical background includes practice in acute care, pulmonary and intensive care medicine, emergency response leadership, post-acute care, palliative care, and hospice. She practiced in high acuity academic healthcare systems throughout Boston and New England, developing deep insight into early intervention, interdisciplinary coordination, and safe, effective transitions across settings of care.

In executive leadership roles, Catherine has led organizational performance, clinical governance, workforce strategy, and financial sustainability initiatives. Her work centers on building integrated, metrics-driven care models that improve outcomes, reduce fragmentation, and strengthen accountability across the healthcare continuum. She brings particular expertise in transitional care medicine, aligning acute, post-acute, and community-based services to support complex, high-need populations over time.

As an Advisory Board Member, Catherine provides strategic guidance on care delivery design, cross-sector collaboration, and scalable models that balance clinical rigor with operational and financial discipline. She contributes a systems-level perspective informed by frontline clinical experience, executive accountability, and public health-oriented approaches to community partnership and longitudinal care.

Catherine holds an MBA, a Master of Science in Physician Assistant Studies, and a Bachelor of Science in Cardiopulmonary Sciences. She is a Fellow of the American College of Healthcare Executives (FACHE) and is recognized for her ability to bridge clinical insight with strategic execution in complex care environments.

Damon's leadership in healthcare and the US Air Force will serve him well on the Advisory Board for Alzheimer's Treatment Centers of America where our mission is to restore hope, improve quality of life, and stand on the front lines of change for patients and their families.

Damon served as Region Vice President for Wellpath Healthcare originally leading 30 healthcare clinics in California and was promoted to lead Oregon and Washington with 60 total clinics with revenue of $180M, the largest region at Wellpath. Damon beat revenue goals by 1.6% by expanding services at existing clinics. Damon opened 3 new clinics based on marketing the successes of existing clinics.

Damon's leadership in healthcare and the US Air Force will serve him well on the Advisory Board for Alzheimer's Treatment Centers of America where our mission is to restore hope, improve quality of life, and stand on the front lines of change for patients and their families.

Damon served as Region Vice President for Wellpath Healthcare originally leading 30 healthcare clinics in California and was promoted to lead Oregon and Washington with 60 total clinics with revenue of $180M, the largest region at Wellpath. Damon beat revenue goals by 1.6% by expanding services at existing clinics. Damon opened 3 new clinics based on marketing the successes of existing clinics.

At DaVita Dialysis, Damon served as a Region Director for 15 clinics and turned around an underperforming region facing Immediate Jeopardy (IJ) by CMMS. The region improved from the 4th quartile on DaVita's Leadership Dashboard (clinical, financial, talent & compliance metrics) to the 1st quartile by leading SWOT sessions with his new team and assigning captainships to key metrics. The team rallied around their SWOT since they created the goals and as the metrics improved, each champion had specific results they owned for their performance reviews. His focus on talent development resulted in one Facility Administrator improving from being on a Performance Improvement Plan (PIP) to being ranked #1 out of 79 Administrators and earning the Shining Star Award for the Division.

Damon was promoted to Senior Director at DaVita and increased his leadership to 64 clinics with over $200M in revenue. Damon streamlined operations to beat revenue goals by 3% by partnering with Kaiser Hospitals to improve the process for patient admissions and increase patient satisfaction scores. In addition to leading his 64 clinics with four Region Directors reporting to him, Damon initiated and led Value Based Care and was the first to achieve 500 patients enrolled in this new Medicare Advantage program. DaVita invited Damon to present his best practices at a national meeting, where his presentation was ranked #1 out of 15.

Damon's leadership began as a US Air Force Special Operations Officer where he served as Director of Operations and earned Logistics Officer of the Year for leading the Squadron to an Outstanding Rating during a bi-annual inspection.

Damon looks forward to leveraging this healthcare and leadership experience to help Alzheimer's Treatment Centers of America fulfill our mission to restore hope, improve quality of life, and stand on the front lines of change for patients and their families.